Evidence map›Paper›PMID 29733684›Full record

ArticleAmyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis2018

MRI feature tracking strain is prognostic for all-cause mortality in AL amyloidosis.

Jeffery E Illman, Shivaram P Arunachalam, Arvin Arani, Ian Cheng-Yi Chang, James F Glockner, Angela Dispenzieri, Martha Grogan, Philip A Araoz

Abstract read
In one paragraph

Article in Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Detection of subclinical myocardial dysfunction in cocaine addicts with feature tracking cardiovascular magnetic resonance.Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · 2020
    Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jeffery E Illmana Department of Radiology , Mayo Clinic , Rochester , MN , USA.
Shivaram P Arunachalama Department of Radiology , Mayo Clinic , Rochester , MN , USA.ORCID http://orcid.org/0000-0003-3251-5415
Arvin Arania Department of Radiology , Mayo Clinic , Rochester , MN , USA.ORCID http://orcid.org/0000-0001-6607-8781
Ian Cheng-Yi Changb Department of Cardiovascular Diseases , Mayo Clinic , MN , USA.ORCID http://orcid.org/0000-0001-6984-4023
James F Glocknera Department of Radiology , Mayo Clinic , Rochester , MN , USA.
Angela Dispenzieric Department of Medicine, Division of Hematology , Mayo Clinic , Rochester , MN , USA.ORCID http://orcid.org/0000-0001-8780-9512
Martha Groganb Department of Cardiovascular Diseases , Mayo Clinic , MN , USA.ORCID http://orcid.org/0000-0002-2541-4440
Philip A Araoza Department of Radiology , Mayo Clinic , Rochester , MN , USA.ORCID http://orcid.org/0000-0001-5465-7997

Funding

Mayo Clinic Center for Translational Science ActivitiesUL1TR000135 · NCATS · MAYO CLINIC ROCHESTER · PI KHOSLA, SUNDEEP · 2012 to 2015
$41.2M
NCATS NIH HHS UL1 TR000135
6 · The paper itself

Abstract

objectivesCardiac involvement is a major determinate of mortality in light chain (AL) amyloidosis. Cardiac magnetic resonance imaging (MRI) feature tracking (FT) strain is a new method for measuring myocardial strain. This study retrospectively evaluated the association of MRI FT strain with all-cause mortality in AL amyloidosis. MATERIALS AND

methodsSeventy-six patients with newly diagnosed AL amyloidosis underwent cardiac MRI. 75 had images suitable for MRI FT strain analysis. MRI delayed enhancement, morphologic and functional evaluation, cardiac biomarker staging and transthoracic echocardiography were also performed. Subjects' charts were reviewed for all-cause mortality. Cox proportional hazards analysis was used to evaluate survival in univariate and multivariate analysis.

resultsThere were 52 deaths. Median follow-up of surviving patients was 1.7 years. In univariate analysis, global radial (Hazard Ratio (HR) = 0.95, p <.01), circumferential (HR = 1.09, p < .01) and longitudinal (HR = 1.08, p < .01) strain were associated with all-cause mortality. In separate multivariate models, radial (HR = 0.96, p = .02), circumferential (HR = 1.09, p = .03) and longitudinal strain (HR = 1.07, p = .04) remained prognostic when combined with presence of biomarker stage 3.

conclusionsMRI FT strain is associated with all-cause mortality in patients with AL amyloidosis.

Indexed as

AgedEchocardiographyFemaleHumansImmunoglobulin Light-chain AmyloidosisKaplan-Meier EstimateMagnetic Resonance ImagingMaleMiddle AgedPrognosisProportional Hazards ModelsRetrospective StudiesAmyloidcardiacfeature-trackingMRIprognosisstrain

Identifiers

PMID29733684
PMCPMC6405287

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.